To include your compound in the COVID-19 Resource Center, submit it here.

Medidur fluocinolone acetonide intravitreal implant: Phase III data

Top-line data from a double-blind, international Phase III trial in 129 patients with recurrent non-infectious uveitis affecting the posterior segment of the eye with or without anterior uveitis showed that 0.18 mg intravitreal Medidur

Read the full 345 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers